Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from NYSE

Expert Ratings for MasTec

MasTec (NYSE:MTZ) has observed the following analyst ratings within the last quarter:

Benzinga

Earnings Preview For Drive Shack

Drive Shack (NYSE:DS) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that Drive Shack will report an earnings per share (EPS) of $-0.14.

Benzinga

Why Ford Stock Looks Set To Reverse

Ford Motor Co (NYSE: F) was falling over 5% lower on Monday in sympathy with the general markets, that saw the S&P decline 2.68%. The legacy-turning-electric vehicle manufacturer has been trading in a fairly consistent downtrend since Jan. 13, losing 47% of its value since that date.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

27 Recession-Resistant Stocks To Look At Now

When we enter a period of economic uncertainty, the phrase "recession-proof stocks" is tossed about, but really the only certainty is that recession-proof stocks do not exist. On the other hand, recession-resistant companies are what a savvy investor searches for during the absence of a bull market, as we are now.

Benzinga

15 Best Dividend Stocks Across These 3 Key Sectors

The Fed’s recent interest rate hike of 0.5% is the most significant in over 20 years. Chairman Jerome Powell expects several additional rate hikes through the end of 2022 and into 2023 amid the highest inflation the United States has seen since December 1981.

Benzinga

Back To McDonald's?: Michael Saylor Pokes Fun At Himself With Bitcoin Crashing

An ongoing joke and often a topic of memes on social media is having to get a fast food job if the price of cryptocurrencies falls lower.

Benzinga

Insurance Stocks Moving In Monday's Intraday Session

According to Benzinga Pro following are the gainers and losers in Insurance industry for today's Intraday session.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Hilton Grand Vacations Shares Slide Post Q1 Results; Plans Buyback

Hilton Grand Vacations Inc (NYSE:HGV) reported first-quarter FY22 sales growth of 231.5% year-on-year, to $779 million, beating the consensus of $763.90 million. Real Estate Sales and Financing segment revenues totaled $452 million, increasing $329 million from last year. Total contract sales in Q1 were $509 million, 96% of Pro-forma combined Q1 2019 contract…

Benzinga

Why Hindenburg Research Is Shorting Twitter: 'Musk Holds All The Cards'

Twitter Inc (NYSE: TWTR) shares traded lower by 4% on Monday, well off the $54.20 per-share buyout price Tesla Inc (NASDAQ: TSLA) CEO Elon Musk has agreed to pay to take Twitter private.

Benzinga

Pilot Study By Cybin Shows That Ketamine Modifies Connectivity Between Brain Regions

Cybin Inc. (NYSE:CYBN) and Kernel, two companies that undertook a joint feasibility study to evaluate the effects ketamine has on blood flow in the brain in late March,&nbs

Benzinga

Mid-Day Market Update: Nasdaq Dips 450 Points; Hemisphere Media Group Shares Surge

U.S. stocks extended losses midway through trading, with the Nasdaq Composite dropping around 450 points on Monday.

Benzinga

Earnings Preview: Myovant Sciences

Myovant Sciences (NYSE:MYOV) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that Myovant Sciences will report an earnings per share (EPS) of $-0.57.

Benzinga

Analyst Ratings for PennyMac Financial Servs

Over the past 3 months, 4 analysts have published their opinion on PennyMac Financial Servs (NYSE:PFSI) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

Where PPL Stands With Analysts

Analysts have provided the following ratings for PPL (NYSE:PPL) within the last quarter:

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

40 Stocks Moving In Monday's Mid-Day Session

Gainers

Benzinga

Teladoc Health Whale Trades Spotted

Someone with a lot of money to spend has taken a bearish stance on Teladoc Health (NYSE:TDOC). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Tyson Foods Beef Up FY22 Outlook On Solid Q2 Earnings

Tyson Foods, Inc. (NYSE:TSN) reported second-quarter FY22 sales growth of 16.1% year-on-year, to $13.12 billion, beating the consensus of $12.84 billion. Sales volume of Beef rose 0.6% Y/Y, Pork fell 4.8%, Chicken climbed 0.6%, and Prepared Foods decreased 5.3%. Gross profit increased 38.5% Y/Y to $1.7 billion, with the margin expanding 210…

Benzinga

Bank of America Whale Trades Spotted

A whale with a lot of money to spend has taken a noticeably bearish stance on Bank of America. Looking at options history for Bank of America (NYSE:BAC) we detected 26 strange trades.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Wells Fargo Maintains Overweight Rating for Barings BDC: Here's What You Need To Know

Wells Fargo has decided to maintain its Overweight rating of Barings BDC (NYSE:BBDC) and lower its price target from $12.50 to $12.00. Shares of Barings BDC are trading down 2.25% over the last 24 hours, at $10.20 per share. A move to $12.00 would account for a 17.7% increase from…

Benzinga

11 Analysts Have This to Say About Aptiv

Over the past 3 months, 11 analysts have published their opinion on Aptiv (NYSE:APTV) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

Canaccord Genuity Maintains Buy Rating for Evolent Health: Here's What You Need To Know

Canaccord Genuity has decided to maintain its Buy rating of Evolent Health (NYSE:EVH) and raise its price target from $40.00 to $45.00. Shares of Evolent Health are trading down 2.43% over the last 24 hours, at $27.84 per share.

Benzinga

BofA Initiates Coverage Of This Athletic Shoe Maker With Underperform Rating

Although On Holding AG (NYSE: ONON) is well positioned to gain share in the global sportswear market, estimated at $410 billion, there are concerns around the company’s long-term growth and margin aspirations, given “execution risk to achieving scale and subpar levels of marketing investment,&rdqu

Benzinga

Why Energizer Shares Are Gaining Today

Energizer Holdings Inc (NYSE:ENR) reported second-quarter FY22 sales of $685.4 million, beating the consensus of $655.38 million. The gross margin for the quarter contracted 470 basis points to 34.8%. Selling, general and administrative expenses were nearly flat at $123.4 million. The company held $213.2 million in cash and equivalents as of March 31,…

Benzinga

$100 Invested In Sempra Energy 20 Years Ago Would Be Worth This Much

Sempra Energy (NYSE:SRE) has outperformed the market over the past 20 years by 3.3% on an annualized basis producing an average annual return of 9.97%. Currently, Sempra Energy has a market capitalization of $51.50 billion.

Benzinga

Here's Why Palantir Looks Set To Bounce

Palantir Technologies, Inc (NYSE: PLTR) fell to a new all-time low of $7.32 on Monday after printing mixed first-quarter financial results and guiding its second-quarter revenue below analyst

1 … 273 274 275 276

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.